MYDA Advisors LLC Makes New Investment in Molina Healthcare, Inc $MOH

MYDA Advisors LLC bought a new stake in Molina Healthcare, Inc (NYSE:MOH) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 12,000 shares of the company’s stock, valued at approximately $2,082,000.

A number of other institutional investors also recently made changes to their positions in MOH. Torren Management LLC acquired a new position in shares of Molina Healthcare in the 4th quarter valued at approximately $26,000. Miller Global Investments LLC acquired a new position in shares of Molina Healthcare in the 4th quarter valued at approximately $27,000. Cromwell Holdings LLC raised its position in shares of Molina Healthcare by 211.9% in the 4th quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock valued at $32,000 after purchasing an additional 125 shares in the last quarter. Quarry LP acquired a new position in shares of Molina Healthcare in the 4th quarter valued at approximately $32,000. Finally, Triumph Capital Management raised its position in shares of Molina Healthcare by 4,625.0% in the 4th quarter. Triumph Capital Management now owns 189 shares of the company’s stock valued at $33,000 after purchasing an additional 185 shares in the last quarter. 98.50% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, insider Jeff D. Barlow sold 17,811 shares of the stock in a transaction on Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the sale, the insider directly owned 67,175 shares of the company’s stock, valued at $12,502,611. This trade represents a 20.96% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CAO Maurice Hebert sold 600 shares of the stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the completion of the sale, the chief accounting officer directly owned 12,815 shares in the company, valued at $2,454,713.25. This represents a 4.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 1.44% of the stock is owned by company insiders.

Molina Healthcare Price Performance

Shares of NYSE MOH opened at $200.55 on Monday. Molina Healthcare, Inc has a 1-year low of $121.06 and a 1-year high of $311.52. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63. The business’s fifty day moving average price is $174.79 and its two-hundred day moving average price is $164.63. The firm has a market capitalization of $10.45 billion, a PE ratio of 59.33 and a beta of 0.80.

Molina Healthcare (NYSE:MOH) last issued its earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.78. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The firm had revenue of $10.80 billion for the quarter, compared to analyst estimates of $10.91 billion. During the same period last year, the company earned $6.08 earnings per share. The firm’s revenue for the quarter was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, research analysts expect that Molina Healthcare, Inc will post 5.23 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. Wall Street Zen raised Molina Healthcare from a “sell” rating to a “hold” rating in a research report on Saturday, May 2nd. Cantor Fitzgerald upped their target price on Molina Healthcare from $144.00 to $209.00 and gave the company a “neutral” rating in a research report on Monday, May 11th. Robert W. Baird upped their target price on Molina Healthcare from $124.00 to $163.00 and gave the company a “neutral” rating in a research report on Monday, May 11th. Morgan Stanley upped their target price on Molina Healthcare from $146.00 to $167.00 and gave the company an “equal weight” rating in a research report on Thursday, June 4th. Finally, Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Molina Healthcare in a research report on Friday, March 13th. Three analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, Molina Healthcare currently has a consensus rating of “Hold” and an average price target of $182.73.

Molina Healthcare Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.